Remove Clinical Trials Remove Epilepsy Remove Packaging Remove Topical
article thumbnail

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Cannabis Law Report

Once completed, it is our intention to immediately submit our IND package to the FDA so that we may begin human trials,” commented Virpax’s Chairman & CEO Anthony P. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. Forward-Looking Statement.

article thumbnail

Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

Cannabis Law Report

We are looking forward to the completion of the required IND enabling studies and submitting our IND package to the FDA in anticipation of first-in-human trials,” continued Mr. Mack. for its MET for the nasal delivery of cannabidiol (CBD) for the management of epilepsy in children (rare pediatric disease) and adults.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. References. 1Alexandra L.

article thumbnail

Cannabis in Israel, with Itai Rogel

The Cannigma

We have autism and epilepsy. I don’t know if we’ll have topicals initially, or later on. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil. Cannabis is given to oncology patients, palliative patients.

article thumbnail

Meritas Law Firms Worldwide Article: Global Cannabis Industry: The Essential Primer

Cannabis Law Report

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.

Law 40